CAS: 937-39-3; 2-Phenylacetohydrazide

该化合物是一种多用途有机化合物,分子式为C8H10N2O.它是合成药物,农用化学品和异环化合物的关键中间体.苯基和氢氮化物功能组的存在增强了其反应性,使其对凝聚反应和形成氢化区衍生物具有价值.其明确界定的结构和高纯度确保研究和工业应用的一贯性.该化合物在药用化学中特别有助于开发生物活性分子,包括抗微生物和抗图象剂.在标准条件下的稳定性以及与普通溶剂的兼容性进一步增强了其在有机合成中的用途.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

Benzeneacetamide Ethyl 2-phenylethanoate 2-benzylidene-oxazolidine-4,5-dione 1-nitroso-2-phenylethane dimerpiperonal-(phenylacetyl-hydrazone) N-acetyl-N'-phenylacetylhydrazine phenyl-acetic acid-(4-chloro-benzylidenehydrazide) N'-benzylidene-2-phenylacetohydrazide

合成工艺路线路线简述

    苯基丙酮置于hydrazine Hydrate体系中,化学反应生成 苯乙酸肼
    参考文献:一种协同抗生素靶向治疗金黄色葡萄球菌感染的抗菌药物及其合成方法和应用
    标题:一种协同抗生素靶向治疗金黄色葡萄球菌感染的抗菌药物及其合成方法和应用
    摘要:本发明基于β‑内酰胺类抗生素分子母核结构之β‑内酰胺环,设计,合成了一类针对金黄色葡萄球菌的新型抗菌药物asc,Asc不仅本身是一类抗菌试剂,而且还是一类β‑内酰胺类抗生素耐药靶蛋白金属β‑内酰胺酶的广谱型抑制剂,Asc可协同β‑内酰胺类,氨基糖苷类和四环素类三类7‑8种抗生素靶向性治疗金黄色葡萄球菌的感染.联用1μg/ml剂量的asc,使得这些抗生素的活力提高4‑128倍.

    海关参考信息

    专利信息


    专利号:US-2025129021-A1
    优先权日:2023-09-19
    标 题:Small molecule protein synthesis modulators
    发明人:GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
    权利人:INTERDICT BIO INC
    摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I), Formula (V)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

    专利号:US-7026339-B2
    优先权日:2003-11-07
    标题 :Inhibitors of HCV NS5B polymerase
    发明人:YANG FAN; ZHANG BO; WICNIENSKI NANCY ANNE; PFEFFERKORN JEFFREY ALLEN; GREENE MEREDITH L; CHEN KE; NUGENT RICHARD A; REDING MATTHEW TODD; KELLY ROBERT CHARLES; MITCHELL MARK A; FUNK LEE A; HEIER III RICHARD FREDERICK; ANDERSON REBECCA MERRY
    权利人:YANG FAN; ZHANG BO; WICNIENSKI NANCY ANNE; PFEFFERKORN JEFFREY ALLEN; GREENE MEREDITH L; CHEN KE; NUGENT RICHARD A; REDING MATTHEW TODD; KELLY ROBERT CHARLES; MITCHELL MARK A; FUNK LEE A; HEIER III RICHARD FREDERICK; ANDERSON REBECCA MERRY
    摘要:The present invention relates to compounds, process for their synthesis, compositions and methods for the treatment and prevention of hepatitis C virus (HCV) infection. In particular, the present invention provides novel compounds, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment or prevention of HCV infection. The present invention also provides processes and intermediates for the synthesis of these compounds.

    专利号:US-2009069334-A1
    优先权日:2007-08-18
    标题:Pyridazine based alpha-helix mimetics
    发明人:REBEK JR JULIUS; BIROS SHANNON; MOISAN LIONEL; VOLONTERIO ALESSANDRO; MANN ENRIQUE; DALE TREVOR
    权利人:SCRIPPS RESEARCH INST
    摘要:The synthesis of new α-helix scaffolds mimicking i, i+3 or i+4, i+7 residues, was accomplished. The common pyridazine heterocycle originates from the easily available building block, 6. These scaffolds may be thought of as synthetic counterparts of amphiphilic α-helices having a “wet faceâ€? along one side and a hydrophobic face along the other side of the helix.

    专利号:CN-118221600-A
    优先权日:2024-01-25
    标 题:One-pot synthesis of metamitron

    专利号:US-2006211603-A1
    优先权日:2004-08-18
    标 题:Ramoplanin derivatives possessing antibacterial activity
    发明人:RAJU BORE G; CIABATTI ROMEO; MAFFIOLI SONIA I; SINGH UPINDER; ROMANO GABRIELLA; MICHELUCCI ELENA; TISENI PAOLO S; CANDIANI GIANPAOLO; KIM BUM; O'DOWD HARDWIN
    权利人:VICURON PHARM INC
    摘要:Novel ramoplanin derivatives are disclosed. These ramoplanin derivatives exhibit antibacterial activity. As the compounds of the subject invention exhibit potent activities against gram positive bacteria, they are useful antimicrobial agents. Methods of synthesis and of use of the compounds are also disclosed.

    专利号:CN-114835656-A
    优先权日:2022-05-13
    标 题:A kind of ethyl 1,3,4-oxadiazole acetate and its synthesis method
    上海昊锐医药生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:021-58388037-13472507714👤
    ⚠️参考联系方式
    地址:上海市靖宇东路75号靖宇大楼1707室 工厂地址:金坛市后阳化工区. 邮编:201201
    电话:021-58388037-13472507714
    传真:021-56829747
    邮箱:chrischen@scigm.com, 35177634@qq.com, novelte@gmail.com
    联系人:陈牧
    手机:13472507714
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    上海市靖宇东路75号靖宇大楼1707室 工厂地址:金坛市后阳化工区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江苏新素新材料有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:13914000513👤
    ⚠️参考联系方式
    邮件:13914000513@163.com
    销售经理: 孙文婷经理
    联系电话:13914000513
    手机号码: 13914000513
    传真号码: 0512-66387035
    QQ号:3772422713
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    苏州市浒墅关经济技术开发区
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthesis Of Various Chiral 1,2,4-Triazole-Containing α-Amino Acids From Aspartic Or Glutamic Acids
    作者:Anne-Laure Blayo,Frédéric Brunel,Jean Martinez,Jean-Alain Fehrentz |发布日期:2011.8
    摘要:Starting From N- And C-Protected Aspartic Or Glutamic Acids, New Unnatural α-Amino Acids Containing 3,4,5-Trisubstituted 1,2,4-Triazole Heterocycles On Their Side Chains Have Been Synthesized. Two Points Of Diversity Could Easily Be Achieved On The Heterocyclic Moiety, Which Could Easily Be Incorporated In Peptide Sequences To Modify Or Improve Their Pharmacokinetic Properties.

    合成参考文献


    摘要:Stanovnik, B.; Svete, J., Science of Synthesis, (2002) 12, 34.
    摘要:Braverman, S.; Cherkinsky, M.; Birsa, M. L., Science of Synthesis, (2005) 18, 135.
    摘要:Collier, S. J.; Langer, P., Science of Synthesis, (2004) 19, 403.
    摘要:Schobert, R.; Gordon, G. J., Science of Synthesis, (2004) 27, 1054.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知